RE2O

RE2O is presented by Humedix as a human-tissue product containing acellular allogeneic dermal material. Its 150 mg reference presentation is different from an ordinary HA solution, and the supplied sales pack still needs confirmation.

• Human acellular dermal matrix (hADM)
• Human-tissue material; Humedix reference lists one syringe

Composition

Human acellular dermal matrix (hADM)

Product format

Human-tissue material; Humedix reference lists one syringe

Strength

150 mg per manufacturer reference unit

Pack confirmation

The exact supplied pack needs confirmation; purchase options remain unchanged.

Brand / supplier

Humedix

Storage

1-30 C, according to the Humedix product page.

Humedix lists a 150 mg single-syringe reference unit. The sales pack still needs confirmation; 150 mg is a mass, not a volume.

Professional product: follow the current label and a qualified practitioner's instructions. Container format alone does not establish a permitted route of use.

Sources & review date

• Humedix - RE2O official product informationӨндіруші
• Derma Solution - RE2ORetailer

Information reviewed 2026-10-07. Source references describe the named product; the supplied label identifies its exact version and market.